Monopar Therapeutics Inc. (NASDAQ:MNPR - Free Report) - Research analysts at HC Wainwright raised their FY2026 earnings per share estimates for Monopar Therapeutics in a report released on Thursday, November 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings